Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-23-030794

Director sold 16,000 shares at $24.00 ($384,000)

  • Director acquired 16,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MACARTNEY LAWSON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Exercise or conversion : show line 1 in the form +16,000 $1.19 $19,040 63,965 D
2023-05-16 Sale : show line 2 in the form −16,000 $24.00 $384,000 47,965 D
Open-market sales · 16,000 sh · avg $24.00 · $384,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −16,000 0 D
Loading xslF345X04/doc4.xml…